Palvella Therapeutics (PVLA) Earnings Date, Estimates & Call Transcripts $27.70 +0.15 (+0.54%) As of 07/15/2025 04:00 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Palvella Therapeutics Earnings Summary Palvella Therapeutics posted Q1 2025 earnings on May 15, 2025, reporting an EPS of -$0.74, which topped the consensus estimate of -$3.40 by $2.66. With a trailing EPS of -$12.10, Palvella Therapeutics' earnings are expected to grow next year, from ($3.69) to ($2.77) per share. Upcoming Q2 Earnings DateAug. 13Before Market OpensEstimatedConsensus EPS (May. 15) -$3.40 Actual EPS (May. 15) -$0.74 Beat By $2.66 Q1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Slide DeckPVLA Upcoming EarningsPalvella Therapeutics' Q2 2025 earnings is scheduled for Wednesday, August 13, 2025, with a conference call scheduled on Thursday, August 14, 2025 at 8:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Slide DeckFull Screen Slide DeckPowered by Get Palvella Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Palvella Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Palvella Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$3.56-$3.56-$3.56Q2 20251-$3.79-$3.79-$3.79Q3 20251-$4.05-$4.05-$4.05Q4 20251-$4.33-$4.33-$4.33 Palvella Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/13/2025(Estimated)--------5/15/2025Q1 2025-$3.40-$0.74+$2.66-$0.74-- Palvella Therapeutics Earnings - Frequently Asked Questions When is Palvella Therapeutics' earnings date? Palvella Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 13th, 2025 based off last year's report dates. Learn more on PVLA's earnings history. Did Palvella Therapeutics beat their earnings estimates last quarter? In the previous quarter, Palvella Therapeutics (NASDAQ:PVLA) reported ($0.74) earnings per share (EPS) to beat the analysts' consensus estimate of ($3.40) by $2.66. Learn more on analysts' earnings estimate vs. PVLA's actual earnings. How can I listen to Palvella Therapeutics' earnings conference call? The conference call for Palvella Therapeutics' latest earnings report can be listened to online. Listen to Conference Call How can I read Palvella Therapeutics' conference call transcript? The conference call transcript for Palvella Therapeutics' latest earnings report can be read online. Read Transcript How much revenue does Palvella Therapeutics generate each year? Palvella Therapeutics (NASDAQ:PVLA) has a recorded annual revenue of $42.81 million. How much profit does Palvella Therapeutics generate each year? Palvella Therapeutics (NASDAQ:PVLA) has a recorded net income of -$17.43 million. PVLA has generated -$12.10 earnings per share over the last four quarters. What is Palvella Therapeutics' EPS forecast for next year? Palvella Therapeutics' earnings are expected to grow from ($3.69) per share to ($2.77) per share in the next year. More Earnings Resources from MarketBeat Related Companies PROK Earnings Date WVE Earnings Date GPCR Earnings Date ARDX Earnings Date AMPH Earnings Date AUPH Earnings Date CDTX Earnings Date COLL Earnings Date VERV Earnings Date ELVN Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles 3 Analysts Set $600 Target Ahead of Microsoft EarningsTesla: 2 Plays Ahead of Next Week's Earnings ReportFastenal Surges After Earnings Beat, Tariff Risks Loom3 Catalysts Converge on Intel Ahead of a Critical Earnings ReportSmith & Wesson Stock Falls on Earnings Miss, Tariff WoesWhat to Expect From the Q2 Earnings Reporting CycleBroadcom Slides on Solid Earnings, AI Outlook Still Strong This page (NASDAQ:PVLA) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCentral Banks Are Hoarding Gold – Should You?The AI boom isn’t just transforming technology—it’s redefining global power, increasing government debt, and u...Lear Capital | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredAll New Social Security Numbers coming July 23?To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Next Commodity Crisis Just Got a Name: SilverElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Palvella Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Palvella Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.